Iceland· IS-EU/1/21/1530/005-007
Ontozry
A cenobamate product containing cenobamatum inn, registered in Iceland by Angelini Pharma S.p.A. The same ATC class is registered in 15 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Cenobamate is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AX25 (cenobamate), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Cenobamate · ATC N03AX25
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cenobamate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $4.11 in France to $21.72 in Switzerland — a ×5.3 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cenobamate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$21.72
- IT Italy$19.89
- CZ Czechia$4.12
- FR France$4.11
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Cenobamatum INN
- Manufacturer
- Angelini Pharma S.p.A
- Country
- Iceland (IS)
- ATC code
- N03AX25
- ATC class
- Cenobamate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean99355228 stk x1 pakkiISK 31083
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
273 interactions on record for cenobamate.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cenobamate · interactions on record
273 records
- 29 severe
- 237 moderate
- 7 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cenobamate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONTOZRYAngelini Pharma S.p.A, Rome
- SwitzerlandOntozry 100 mg, FilmtablettenAngelini Pharma S.p.A., Rom, Zweigniederlassung Zug
- FinlandOntozryAbacus Medicine A/S
- United StatesXcopriSK Life Science, Inc.
- NetherlandsOntozry 100mg, filmomhulde tabletAngelini Pharma S.p.A
- NorwayOntozryAngelini Pharma S.p.A.
- PolandOntozryAngelini Pharma S.p.A.
- SwedenOntozry 100 mg Filmdragerad tablettAngelini Pharma S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ontozry
- Norway · Ontozry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef499775-b91d-4fd2-885c-ce144ff67c7e GET /v1/drugs/ef499775-b91d-4fd2-885c-ce144ff67c7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "N03AX25",
"marketed": false,
"strength": "100 mg",
"ma_number": "EU/1/21/1530/005-007",
"substance": "Cenobamatum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44281"
}See everything about cenobamate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.